Skip to content

Hepatitis B virus reactivation after allogeneic hematopoietic stem cell transplantation

Hepatitis B virus reactivation after allogeneic hematopoietic stem cell transplantation - HBV reactivation after allogeneic HSCT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000018720
Enrollment
50
Registered
2015-08-19
Start date
2015-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with resolved HBV infection who underwent HSCT

Interventions

None listed

Sponsors

The center for Liver Disease, Federation of National Public Service Personnel Mutual Aid Associations Hamanomachi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent HSCT 2. Patients with HBs antigen negative, and HBc antibody and/or HBs antibody positive 3. Patients with serum total bilirubin <=2.0mg/dl 4. Patients with serum AST and ALT <= 2.5 x ULN 5. Patients with serum creatinine <= 1.5 xULN 6. Patients with PaO2 >=60Torr on room air or SpO2 >=90% 7.Patients with performance status 0,1 or 2 8. Patients who are 20 to 75 years old 9. Patients who gave consent for this trial

Exclusion criteria

Exclusion criteria: 1. Patients with HIV antibody positive 2. Patients with severe infectious disease (Patients whose general condition seemed to be poor like as septic shock ) 3. Patient who undergo hemodialysis 4. Patients with mental disorder which is object of treatment 5. Patients with poorly controlled DM, HT, or heart failure 6. Patients who are pregnant or nursing 7. Patients who are judged ineligible for this trial

Design outcomes

Primary

MeasureTime frame
Frequency of HBV reactivation after HSCT.

Countries

Japan

Contacts

Public ContactSung Kwan Bae

Federation of National Public Service Personnel Mutual Aid Associations Hamanomachi Hospital The Center for Liver Disease

hai-n@hamanomachi.jp092-721-0831

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026